[A Multi-Center Randomized Controlled Trial of Intrauterine Device Use in Chinese Women].
Ying Li,Su-min Zhang,Feng Chen,Chun-yan Zhang,You-ping Li,Jian Zhou,Peng-cheng Xun,Yang Zhao,Lei Ba,Li Wang,Yu-lin Wu,Jin-xun Xu,Sen-quan Yu,Li,Yu-jun Zhang,Guo-bin Yu,Ai-hua Fang,Jiang-tao Huang,Ai-ping Tian,He-ping Chen
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2011.45.002
2011-01-01
Abstract:OBJECTIVE:To assess the safety and effectiveness of intrauterine device in Chinese women.METHODS:In this multicenter randomized controlled trial, a total of 24 000 women were randomly (1:1:1) into 3 groups of Yuangong Cu 365 (YCu365), Copper T 380A (TCu380A) and Multiload Cu 375 (MLCu375). Clinical outcomes were assessed at 12 months post-insertion, including discontinuation due to pregnancy, expulsion, hemorrhage and downward displacement, etc. The overall and causal-specific discontinuation rates for adverse events were calculated.RESULTS:At the end of the first year, the discontinuation rate of YCu365 (4.21%) was the lowest, followed by TCu380A (8.42%) and MLCu375 (13.91%) (P < 0.01). The differences of discontinuation rates for pregnancy, expulsion, hemorrhage and downward displacement between these IUDs were also significant. MLCu375, side effect without medical treatment, fewer follow-ups, deeper uterine cavity and previous IUD failure were significantly associated with an increased risk of IUD discontinuation.CONCLUSION:The newly developed indomethacin-releasing YCu365 IUD appears to perform the best. However, its long-term safety and cost-effectiveness should be further evaluated.